Cargando…
Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
Autores principales: | Pan, Tuo, Tuoerxun, Tayierjiang, Chen, Xi, Yang, Cheng-Jin, Jiang, Chen-Yu, Zhu, Yi-Fan, Li, Ze-Shi, Jiang, Xin-Yi, Zhang, Hai-Tao, Zhang, He, Wang, Ya-Peng, Chen, Wei, Lu, Li-Chong, Ge, Min, Cheng, Yong-Qing, Wang, Dong-Jin, Zhou, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015605/ https://www.ncbi.nlm.nih.gov/pubmed/36936938 http://dx.doi.org/10.3389/fimmu.2023.1165081 |
Ejemplares similares
-
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Pan, Tuo, et al.
Publicado: (2023) -
The neutrophil elastase inhibitor, sivelestat, attenuates sepsis-related kidney injury in rats
por: Li, Guofu, et al.
Publicado: (2016) -
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors
por: Crocetti, Letizia, et al.
Publicado: (2020) -
Positive Effects of Neutrophil Elastase Inhibitor (Sivelestat) on Gut Microbiome and Metabolite Profiles of Septic Rats
por: Sun, Yali, et al.
Publicado: (2022) -
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
por: Aikawa, Naoki, et al.
Publicado: (2014)